scholarly journals Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells

2018 ◽  
Vol 17 (2) ◽  
pp. 499-507 ◽  
Author(s):  
Kei Namba ◽  
Kazuhiko Shien ◽  
Yuta Takahashi ◽  
Hidejiro Torigoe ◽  
Hiroki Sato ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (9) ◽  
pp. e0162925 ◽  
Author(s):  
Fei Yan ◽  
Jiuxia Pang ◽  
Yong Peng ◽  
Julian R. Molina ◽  
Ping Yang ◽  
...  

2018 ◽  
Author(s):  
Duc-Hiep Bach ◽  
Thi-Thu-Trang Luu ◽  
Dong-Hwa Kim ◽  
Yong Jin An ◽  
Hyen Joo Park ◽  
...  

2013 ◽  
Vol 14 (6) ◽  
pp. 481-491 ◽  
Author(s):  
Mari Iida ◽  
Toni M. Brand ◽  
David A. Campbell ◽  
Megan M. Starr ◽  
Neha Luthar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document